110 related articles for article (PubMed ID: 20191568)
1. Measuring joint involvement in polyarticular psoriatic arthritis: an introduction of alternatives.
Englbrecht M; Wang Y; Ronneberger M; Manger B; Vastesaeger N; Veale DJ; Schett G
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):977-83. PubMed ID: 20191568
[TBL] [Abstract][Full Text] [Related]
2. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease.
Coates LC; FitzGerald O; Gladman DD; McHugh N; Mease P; Strand V; Helliwell PS
Arthritis Rheum; 2013 Jun; 65(6):1504-9. PubMed ID: 23529837
[TBL] [Abstract][Full Text] [Related]
3. Measurement of disease activity in psoriatic arthritis. Extended report.
Ujfalussy I; Koó E
Z Rheumatol; 2003 Feb; 62(1):60-5. PubMed ID: 12624805
[TBL] [Abstract][Full Text] [Related]
4. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
Ringold S; Chon Y; Singer NG
Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
[TBL] [Abstract][Full Text] [Related]
5. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease.
Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG
Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561
[TBL] [Abstract][Full Text] [Related]
6. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis.
Schoels M; Aletaha D; Funovits J; Kavanaugh A; Baker D; Smolen JS
Ann Rheum Dis; 2010 Aug; 69(8):1441-7. PubMed ID: 20525844
[TBL] [Abstract][Full Text] [Related]
7. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
[TBL] [Abstract][Full Text] [Related]
8. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
[TBL] [Abstract][Full Text] [Related]
9. Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
Cauli A; Gladman DD; Mathieu A; Olivieri I; Porru G; Tak PP; Sardu C; Ujfalussy I; Scarpa R; Marchesoni A; Taylor WJ; Spadaro A; Fernàndez-Sueiro JL; Salvarani C; Kalden JR; Lubrano E; Carneiro S; Desiati F; Flynn JA; D'Angelo S; Vacca A; VAN Kuijk AW; Catanoso MG; Gruenke M; Peluso R; Parsons WJ; Ferrara N; Contu P; Helliwell PS; Mease PJ;
J Rheumatol; 2011 May; 38(5):898-903. PubMed ID: 21324965
[TBL] [Abstract][Full Text] [Related]
10. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
11. Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.
Cauza E; Spak M; Cauza K; Hanusch-Enserer U; Dunky A; Wagner E
Rheumatol Int; 2002 Nov; 22(6):227-32. PubMed ID: 12426660
[TBL] [Abstract][Full Text] [Related]
12. Measuring dactylitis in clinical trials: which is the best instrument to use?
Healy PJ; Helliwell PS
J Rheumatol; 2007 Jun; 34(6):1302-6. PubMed ID: 17309128
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis.
Nell-Duxneuner VP; Stamm TA; Machold KP; Pflugbeil S; Aletaha D; Smolen JS
Ann Rheum Dis; 2010 Mar; 69(3):546-9. PubMed ID: 19762363
[TBL] [Abstract][Full Text] [Related]
14. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
Pincus T; Amara I; Koch GG
Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
[TBL] [Abstract][Full Text] [Related]
15. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same?
Tan AL; Grainger AJ; Tanner SF; Emery P; McGonagle D
Arthritis Rheum; 2006 Apr; 54(4):1328-33. PubMed ID: 16575858
[TBL] [Abstract][Full Text] [Related]
16. Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imaging.
Stone MA; White LM; Gladman DD; Inman RD; Chaya S; Lax M; Salonen D; Weber DA; Guthrie JA; Pomeroy E; Podbielski D; Keystone EC
J Rheumatol; 2009 Dec; 36(12):2751-7. PubMed ID: 19918033
[TBL] [Abstract][Full Text] [Related]
17. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT
J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
[TBL] [Abstract][Full Text] [Related]
18. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study.
Furtado RN; Oliveira LM; Natour J
J Rheumatol; 2005 Sep; 32(9):1691-8. PubMed ID: 16142862
[TBL] [Abstract][Full Text] [Related]
19. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis.
Husted J; Gladman DD; Long JA; Farewell VT
J Rheumatol; 1996 Nov; 23(11):1932-7. PubMed ID: 8923369
[TBL] [Abstract][Full Text] [Related]
20. Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term study.
Voulgari PV; Venetsanopoulou AI; Exarchou SA; Alamanos Y; Tsifetaki N; Drosos AA
Semin Arthritis Rheum; 2008 Apr; 37(5):293-8. PubMed ID: 17888499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
